SCHEMBL7142096

SCHEMBL7142096

Cc1ccc(C)c(-c2ncc[nH]2)c1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.61
MTOR P42345 1/20 0.61
ADK P55263 1/20 0.61
CSNK1A1 P48729 1/20 0.41
TYRO3 Q06418 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
TAAR1 Q96RJ0 3/20 0.40
BRD4 O60885 2/20 0.39
KMT2A Q03164 2/20 0.39
AKT2 P31751 2/20 0.39
MEN1 O00255 1/20 0.39
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001368 0.80 NISCH (0.52) NISCHMTORADKCSNK1A1TYRO3
Hydrochloric Acid SCHEMBL29265356 0.78 NISCH (0.50) NISCHMTORADKCSNK1A1TYRO3
SCHEMBL18396006 0.77 NISCH (0.63) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL9719773 0.77 NISCH (1.00) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL8901 0.77 NISCH (1.00) NISCHMTORADKCSNK1A1TYRO3
SCHEMBL3053174 0.77 ADRA2A (0.46) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL5796856 0.75 NISCH (0.95) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL8898735 0.75 NISCH (0.95) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL1954238 0.75 NISCH (0.95) NISCHMTORADKCSNK1A1TYRO3
2-Phenylimidazole SCHEMBL11072040 0.75 NISCH (0.95) NISCHMTORADKCSNK1A1TYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515133-B1 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. NEUROGEN CORPORATION 2003-02-04 US disclosed
US-6121260-A Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives NEUROGEN CORPORATION (US) 2000-09-19 US disclosed
EP-0996443-A1 CERTAIN DIARYLIMIDAZOLE DERIVATIVES; A NEW CLASS OF NPY SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-05-03 EP disclosed
WO-1999001128-A1 CERTAIN DIARYLIMIDAZOLE DERIVATIVES; A NEW CLASS OF NPY SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1999-01-14 WO disclosed
US-5560785-A TREATING SURFACE WITH SOLUTION OF IMIDAZOLE COMPOUND, COPPER COMPOUND, ZINC COMPOUND, STABILIZERS SHIKOKU CHEMICALS CORPORATION (JP) 1996-10-01 US disclosed
US-5498301-A ON A PRINTED WIRING BOARD, HEAT RESISTANT, MOISTURE RESISTANT, A 2-ARYLIMIDAZOLE, CARBOXYLIC ACID, AMMONIA, WATER SHIKOKU CHEMICALS CORPORATION (JP) 1996-03-12 US disclosed
EP-0627499-A1 Agent for treating surfaces of copper and copper alloys SHIKOKU CHEMICALS CORPORATION (JP) 1994-12-07 EP disclosed